(1->4)-beta-D-glucan multiple interactions ISO RGD:1318277 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SFXN1 mRNA CTD PMID:36331819 1,1-dichloroethene decreases expression ISO RGD:1318277 6480464 vinylidene chloride results in decreased expression of SFXN1 mRNA CTD PMID:26682919 1,2-dimethylhydrazine multiple interactions ISO RGD:1318277 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SFXN1 mRNA CTD PMID:22206623 17alpha-ethynylestradiol affects expression ISO RGD:1318277 6480464 Ethinyl Estradiol affects the expression of SFXN1 mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:1318277 6480464 Ethinyl Estradiol results in increased expression of SFXN1 mRNA CTD PMID:17942748 17alpha-ethynylestradiol multiple interactions ISO RGD:1318277 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFXN1 mRNA CTD PMID:17942748 17beta-estradiol affects expression ISO RGD:1318277 6480464 Estradiol affects the expression of SFXN1 mRNA CTD PMID:16684588 2,2,2-tetramine multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of SFXN1 protein] CTD PMID:19634143 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1318277 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SFXN1 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to SFXN1 gene] CTD PMID:17942748 , PMID:21762485 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SFXN1 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1318277 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFXN1 mRNA CTD PMID:28213091 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SFXN1 mRNA CTD PMID:16960034 , PMID:26232522 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of SFXN1 mRNA CTD PMID:18796159 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1318277 6480464 Tetrachlorodibenzodioxin affects the expression of SFXN1 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1318277 6480464 Tetrachlorodibenzodioxin results in increased expression of SFXN1 mRNA CTD PMID:16960034 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of SFXN1 mRNA CTD PMID:21346803 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:20959002 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SFXN1 mRNA CTD PMID:36041667 4-hydroxyphenyl retinamide increases expression ISO RGD:1318277 6480464 Fenretinide results in increased expression of SFXN1 mRNA CTD PMID:28973697 5-methoxy-2-\{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl\}-1H-benzimidazole affects expression EXP 6480464 Omeprazole affects the expression of SFXN1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil affects expression EXP 6480464 Propylthiouracil affects the expression of SFXN1 mRNA CTD PMID:19483382 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of SFXN1 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SFXN1 mRNA CTD PMID:31881176 aflatoxin B1 increases methylation ISO RGD:1318276 6480464 Aflatoxin B1 results in increased methylation of SFXN1 intron CTD PMID:30157460 amiodarone affects expression EXP 6480464 Amiodarone affects the expression of SFXN1 mRNA CTD PMID:19483382 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SFXN1 mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:1318276 6480464 aristolochic acid I results in decreased expression of SFXN1 mRNA CTD PMID:33212167 arsenite(3-) increases methylation ISO RGD:1318276 6480464 arsenite results in increased methylation of SFXN1 promoter CTD PMID:23974009 arsenite(3-) multiple interactions ISO RGD:1318276 6480464 arsenite promotes the reaction [G3BP1 protein binds to SFXN1 protein] CTD PMID:32406909 benzbromarone affects expression EXP 6480464 Benzbromarone affects the expression of SFXN1 mRNA CTD PMID:19483382 benzo[a]pyrene increases methylation ISO RGD:1318276 6480464 Benzo(a)pyrene results in increased methylation of SFXN1 promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1318276 6480464 Benzo(a)pyrene results in decreased expression of SFXN1 protein CTD PMID:33278487 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1318276 6480464 7 more ... CTD PMID:19150397 bisphenol A decreases expression ISO RGD:1318276 6480464 bisphenol A results in decreased expression of SFXN1 mRNA CTD PMID:22576693 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SFXN1 mRNA CTD PMID:36041667 bisphenol A increases expression ISO RGD:1318277 6480464 bisphenol A results in increased expression of SFXN1 mRNA CTD PMID:33221593 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SFXN1 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SFXN1 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:1318276 6480464 bisphenol A results in increased methylation of SFXN1 gene CTD PMID:22576693 Bisphenol B increases expression ISO RGD:1318276 6480464 bisphenol B results in increased expression of SFXN1 protein CTD PMID:34186270 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of SFXN1 mRNA CTD PMID:36041667 butanal decreases expression ISO RGD:1318276 6480464 butyraldehyde results in decreased expression of SFXN1 mRNA CTD PMID:26079696 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of SFXN1 mRNA CTD PMID:33453195 carbon nanotube multiple interactions ISO RGD:1318276 6480464 [Nanotubes, Carbon co-treated with calfactant] results in decreased expression of SFXN1 protein CTD PMID:23026733 carbon nanotube increases expression ISO RGD:1318277 6480464 Nanotubes more ... CTD PMID:25554681 , PMID:25620056 CGP 52608 multiple interactions ISO RGD:1318276 6480464 CGP 52608 promotes the reaction [RORA protein binds to SFXN1 gene] CTD PMID:28238834 chlordecone decreases expression ISO RGD:1318277 6480464 Chlordecone results in decreased expression of SFXN1 mRNA CTD PMID:33711761 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of SFXN1 protein CTD PMID:22023808 clofibrate affects expression EXP 6480464 Clofibrate affects the expression of SFXN1 mRNA CTD PMID:19483382 clofibrate multiple interactions ISO RGD:1318277 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SFXN1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SFXN1 mRNA] CTD PMID:17585979 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SFXN1 mRNA CTD PMID:17602206 clozapine multiple interactions ISO RGD:1318276 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of SFXN1 protein CTD PMID:34122009 cobalt dichloride decreases expression ISO RGD:1318276 6480464 cobaltous chloride results in decreased expression of SFXN1 mRNA CTD PMID:19320972 copper atom multiple interactions ISO RGD:1318276 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SFXN1 mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1318276 6480464 [NSC 689534 binds to Copper] which results in decreased expression of SFXN1 mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1318276 6480464 Copper Sulfate results in decreased expression of SFXN1 mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:1318276 6480464 Coumestrol results in decreased expression of SFXN1 mRNA CTD PMID:19167446 Cuprizon multiple interactions ISO RGD:1318276 6480464 [Cuprizone co-treated with Clozapine] results in decreased expression of SFXN1 protein CTD PMID:34122009 curcumin decreases expression ISO RGD:1318276 6480464 Curcumin results in decreased expression of SFXN1 mRNA CTD PMID:18421014 cyclosporin A decreases expression ISO RGD:1318276 6480464 Cyclosporine results in decreased expression of SFXN1 mRNA CTD PMID:20106945 cyclosporin A affects methylation ISO RGD:1318276 6480464 Cyclosporine affects the methylation of SFXN1 promoter CTD PMID:27989131 diethyl maleate decreases expression ISO RGD:1318277 6480464 diethyl maleate results in decreased expression of SFXN1 mRNA CTD PMID:25270620 doxorubicin affects response to substance ISO RGD:1318276 6480464 SFXN1 protein affects the susceptibility to Doxorubicin CTD PMID:16217747 ethanol affects splicing ISO RGD:1318277 6480464 Ethanol affects the splicing of SFXN1 mRNA CTD PMID:30319688 flutamide increases expression EXP 6480464 Flutamide results in increased expression of SFXN1 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1318277 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SFXN1 mRNA CTD PMID:22206623 formaldehyde decreases expression ISO RGD:1318276 6480464 Formaldehyde results in decreased expression of SFXN1 mRNA CTD PMID:23649840 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of SFXN1 mRNA CTD PMID:33387578 glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SFXN1 mRNA CTD PMID:24136188 glutathione increases expression EXP 6480464 Glutathione deficiency results in increased expression of SFXN1 mRNA CTD PMID:15345336 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of SFXN1 mRNA CTD PMID:21396975 ivermectin decreases expression ISO RGD:1318276 6480464 Ivermectin results in decreased expression of SFXN1 protein CTD PMID:32959892 L-ethionine affects expression EXP 6480464 Ethionine affects the expression of SFXN1 mRNA CTD PMID:19483382 lamivudine multiple interactions ISO RGD:1318277 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN1 mRNA CTD PMID:18313992 lead(0) affects splicing ISO RGD:1318276 6480464 Lead affects the splicing of SFXN1 mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:1318276 6480464 Lead affects the splicing of SFXN1 mRNA CTD PMID:28903495 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of SFXN1 mRNA CTD PMID:24136188 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of SFXN1 mRNA CTD PMID:30467583 methyl methanesulfonate decreases expression ISO RGD:1318276 6480464 Methyl Methanesulfonate results in decreased expression of SFXN1 mRNA CTD PMID:23649840 N-methyl-4-phenylpyridinium increases expression ISO RGD:1318276 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SFXN1 protein CTD PMID:24675778 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of SFXN1 mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of SFXN1 mRNA CTD PMID:17602206 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of SFXN1 mRNA CTD PMID:24136188 omeprazole affects expression EXP 6480464 Omeprazole affects the expression of SFXN1 mRNA CTD PMID:19483382 p-toluidine increases expression EXP 6480464 4-toluidine results in increased expression of SFXN1 mRNA CTD PMID:27638505 paracetamol multiple interactions ISO RGD:1318277 6480464 [Clofibrate co-treated with Acetaminophen] affects the expression of SFXN1 mRNA, PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of SFXN1 mRNA] CTD PMID:17585979 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of SFXN1 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1318276 6480464 Acetaminophen results in decreased expression of SFXN1 mRNA CTD PMID:21420995 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1318277 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SFXN1 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO RGD:1318277 6480464 NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SFXN1 mRNA] CTD PMID:19482888 phenobarbital decreases expression ISO RGD:1318277 6480464 Phenobarbital results in decreased expression of SFXN1 mRNA CTD PMID:19482888 pirinixic acid increases expression ISO RGD:1318277 6480464 pirinixic acid results in increased expression of SFXN1 mRNA CTD PMID:18301758 pirinixic acid affects expression EXP 6480464 pirinixic acid affects the expression of SFXN1 mRNA CTD PMID:19483382 Propiverine affects binding EXP 6480464 propiverine binds to SFXN1 protein CTD PMID:29273565 rifampicin decreases expression ISO RGD:1318276 6480464 Rifampin results in decreased expression of SFXN1 mRNA CTD PMID:24552687 sodium arsenite increases expression ISO RGD:1318276 6480464 sodium arsenite results in increased expression of SFXN1 mRNA CTD PMID:34032870 streptozocin multiple interactions EXP 6480464 Trientine inhibits the reaction [Streptozocin results in increased expression of SFXN1 protein] CTD PMID:19634143 streptozocin increases expression EXP 6480464 Streptozocin results in increased expression of SFXN1 protein CTD PMID:19634143 tamoxifen affects expression ISO RGD:1318277 6480464 Tamoxifen affects the expression of SFXN1 mRNA CTD PMID:17555576 thioacetamide affects expression EXP 6480464 Thioacetamide affects the expression of SFXN1 mRNA CTD PMID:19483382 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SFXN1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO RGD:1318277 6480464 titanium dioxide results in decreased expression of SFXN1 mRNA CTD PMID:23557971 tolcapone affects binding EXP 6480464 tolcapone binds to SFXN1 protein CTD PMID:19783845 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SFXN1 mRNA CTD PMID:33387578 trichostatin A increases expression ISO RGD:1318276 6480464 trichostatin A results in increased expression of SFXN1 mRNA CTD PMID:24935251 trimellitic anhydride increases expression ISO RGD:1318277 6480464 trimellitic anhydride results in increased expression of SFXN1 mRNA CTD PMID:19042947 tunicamycin decreases expression ISO RGD:1318276 6480464 Tunicamycin results in decreased expression of SFXN1 mRNA CTD PMID:22378314 valproic acid decreases expression ISO RGD:1318276 6480464 Valproic Acid results in decreased expression of SFXN1 mRNA CTD PMID:23179753 more ... vincaleukoblastine affects response to substance ISO RGD:1318276 6480464 SFXN1 protein affects the susceptibility to Vinblastine CTD PMID:16217747 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of SFXN1 mRNA CTD PMID:22570695 zidovudine multiple interactions ISO RGD:1318277 6480464 [Zidovudine co-treated with Lamivudine] results in increased expression of SFXN1 mRNA CTD PMID:18313992